Single-use Bioprocessing Market Summary

The global single-use bioprocessing market was valued at USD 31.71 billion in 2024 and is projected to reach USD 74.09 billion by 2030, expanding at a compound annual growth rate (CAGR) of 15.44% from 2025 to 2030. The increasing adoption of single-use bioprocessing technologies is primarily driven by the rising demand for biopharmaceutical products. Over the past few years, there has been a surge in investments targeted toward the development of biologics, including monoclonal antibodies, recombinant proteins, vaccines, and other advanced therapies, all of which require efficient, flexible, and scalable production platforms.

Single-use bioprocessing systems offer significant advantages, such as reduced capital and operational costs, shorter production timelines, and enhanced facility flexibility. These benefits have made single-use technologies a preferred choice for modern biomanufacturing facilities. The technology also eliminates the need for cleaning and sterilization processes, thereby reducing the risk of cross-contamination and enhancing operational efficiency. The growing popularity of these systems continues to reshape traditional bioprocessing methods, particularly in clinical and commercial-scale biologics production.

The COVID-19 pandemic significantly accelerated the implementation of single-use technologies, creating new growth avenues for stakeholders across the value chain. With the urgent need for rapid vaccine and therapeutic development, many biopharmaceutical manufacturers scaled up their operations using single-use bioprocessing equipment. These technologies enabled faster facility construction and batch turnaround times, making them ideal for responding to global health emergencies. As a result, a substantial number of companies involved in the production of COVID-19 vaccines adopted single-use systems, leveraging their benefits of cost-efficiency, flexibility, and minimized risk of cross-contamination in high-speed manufacturing environments.

Key Market Trends & Insights

• In 2024, the simple and peripheral elements segment emerged as the leading product category, accounting for the largest market share of 82%. This dominance can be attributed to ongoing innovations in single-use components, including tubing, connectors, clamps, and filters, which are vital for streamlining fluid transfer and bioprocessing operations. The increasing importance of these components in core biomanufacturing processes continues to support their demand.
• The upstream bioprocessing segment held the highest market share of 23% in 2024 and is projected to grow at the fastest rate during the forecast period. Upstream applications such as cell culture, media preparation, and fermentation heavily rely on single-use systems for efficient, contamination-free processing. The rapid growth of biologics manufacturing further boosts the demand for single-use technologies in upstream workflows.
• In terms of end users, biopharmaceutical manufacturers dominated the single-use bioprocessing market in 2024. This segment benefits from the growing adoption of flexible, scalable manufacturing solutions required for producing biologics and biosimilars. The increasing complexity of biologic drugs and the need for cost-effective production methods drive manufacturers to invest in advanced single-use platforms.
• North America accounted for the largest revenue share of more than 34.96% in 2024. This strong market position is attributed to the well-established pharmaceutical and biomanufacturing industries in the region. Furthermore, the region's advanced infrastructure, high R&D investments, and strong regulatory frameworks support the integration of single-use technologies into clinical and commercial manufacturing processes.
• The Asia Pacific region is expected to experience the fastest growth over the forecast period. The region's expanding bioprocessing sector has attracted substantial investments from global biopharma companies. These investments aim to enhance regional manufacturing capabilities and enable multinational firms to tap into untapped markets. With increasing government support and rising demand for biologics across countries like China, India, and South Korea, Asia Pacific is poised to become a significant hub for single-use bioprocessing innovation and expansion.

Order a free sample PDF of the Single-use Bioprocessing Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 31.71 Billion
• 2030 Projected Market Size: USD 74.09 Billion
• CAGR (2025-2030): 15.44%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights

The market is witnessing several strategic initiatives such as product launches, expansions adopted by key players to increase their reach in the market and to maintain their industry presence. These developments also enhance the availability of their products in diverse geographical areas.

Key Players

• Sartorius AG
• Danaher Corporation
• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Avantor, Inc.
• Eppendorf SE
• Corning Incorporated
• Boehringer Ingelheim International GmbH
• Lonza
• Infors AG

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The single-use bioprocessing market is witnessing remarkable growth due to the rising demand for biologics, cost-effective production needs, and increasing investment in advanced therapies. As biopharmaceutical manufacturers seek flexible, scalable, and contamination-free systems, single-use technologies have become indispensable in both upstream and downstream workflows. The COVID-19 pandemic further underscored their value in accelerating vaccine production. While North America leads in infrastructure and R&D, Asia Pacific presents the fastest growth potential, supported by strategic global investments. With innovations continuing across components and systems, the market is set to play a vital role in shaping the future of biopharmaceutical manufacturing worldwide.